Thyroid dysfunction associated with gonadotropin-releasing hormone analogues: myth or reality?
Wiener klinische Wochenschrift · 30.10.2026
DOI: 10.1007/s00508-026-02850-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Wiener klinische Wochenschrift, online erschienen am 30.10.2026. Verfasst von Alberto Vassallo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetology Unit, ASST Lodi, Via Largo Donatori del Sangue 60, 26900, Lodi, Italy. alberto.vassallo@asst-lodi.it. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Gonadotropin-releasing hormone analogues (GnRHas) are widely used across multiple clinical settings, including hormone-sensitive cancers, benign gynecological conditions, reproductive medicine and central precocious puberty. While the long-term endocrine adverse effects of these agents are well recognized and characterized, their impact on thyroid function remains remarkably underinvestigated in clinical practice.The complex interplay between sex steroids, immune regulation and thyroid homeostasis provides a strong biological rationale for hypothesizing an effect of GnRH-based treatment on thyroid function; however, current evidence is scarce and largely limited to anecdotal reports of autoimmune thyroid disorders and a small number of studies describing biochemical alterations in thyroid hormone parameters following GnRHas administration. While routine screening and monitoring of thyroid function cannot currently be recommended, targeted evaluation in selected individuals may be clinically appropriate.This commentary summarizes the available clinical evidence and discusses potential pathophysiological mechanisms linking GnRH-based treatment to thyroid dysfunction. Rather than providing definitive conclusions, this work aims to highlight an underrecognized endocrine safety issue and to encourage systematic investigation in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology and Diabetology Unit, ASST Lodi, Via Largo Donatori del Sangue 60, 26900, Lodi, Italy. alberto.vassallo@asst-lodi.it.
- Endocrinology and Diabetology Unit, ASST Lodi, Via Largo Donatori del Sangue 60, 26900, Lodi, Italy.
- Ginecology Unit, ASST Cremona, Cremona, Italy.
Zitieren
APA
Vassallo, A., Carbone, A., Tedeschi, S., & Guazzoni, V. (2026). Thyroid dysfunction associated with gonadotropin-releasing hormone analogues: myth or reality?. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-026-02850-5
Vancouver
Vassallo A, Carbone A, Tedeschi S, Guazzoni V. Thyroid dysfunction associated with gonadotropin-releasing hormone analogues: myth or reality?. Wiener klinische Wochenschrift. 2026. doi:10.1007/s00508-026-02850-5
BibTeX
@article{Vassallo2026,
author = {Vassallo, Alberto and Carbone, Andrea and Tedeschi, Sara and Guazzoni, Valeria},
title = {Thyroid dysfunction associated with gonadotropin-releasing hormone analogues: myth or reality?},
journal = {Wiener klinische Wochenschrift},
year = {2026},
doi = {10.1007/s00508-026-02850-5}
}
EUVIMED